Skip to main content

Chromosome Analysis, Blood

Test code(s) 14596

No. Please call Quest Genomics Client Services at 866-GENE-INFO to discuss this case with a genetic counselor. Documentation of the specific genetic abnormality in the family will be necessary to determine the accuracy of the testing that was performed on your patient.

Yes, there are other studies that may be appropriate. There are many causes for developmental disorders, some of which are genetic. In the absence of clinical suspicion for a specific genetic disorder, a microarray analysis may be performed to detect subtle deletions and duplications (test code 16478, Chromosomal Microarray, Postnatal, ClariSure® Oligo-SNP). If clinical suspicion exists for a specific disorder, there may be other genetic testing available. Please contact Quest Genomics Client Services at 866-GENE-INFO to discuss the case with a genetic counselor and for information on adding additional testing.

This assay can rule out:

  1. Trisomies such as trisomy 21 (Down syndrome), trisomy 18, trisomy 13
  2. Sex chromosome abnormalities such as Turner (45,X) and Klinefelter (XXY) syndromes.
  3. Most rearrangements, including Robertsonian translocations, reciprocal translocations, and inversions
  4. Marker chromosomes
  5. Mosaicism at or above 14% (at a 95% confidence level)
  6. Most microscopically visible structural abnormalities

This assay cannot detect:

  1. Most microdeletion syndromes, including DiGeorge, Prader Willi, Angelman, Williams, and Smith Magenis
  2. Mosaicism below 14% (at a 95% confidence level)
  3. Single gene disorders such as fragile X syndrome, cystic fibrosis, Marfan syndrome, neurofibromatosis, etc.

This FAQ is provided for informational purposes only and is not intended as medical advice. A clinician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

Document FAQS.49 Version: 2
Version 2 effective 04/19/2016 to present
Version 1 effective 03/25/2014 to 04/18/2016
Version 0 effective 05/04/2012 to 03/24/2014